Dr. Reddy’s Laboratories Limited (NYSE:RDY) was downgraded by equities research analysts at TheStreet from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday. Dr. Reddy’s Laboratories Limited (ADR) (NYSE:RDY) net profit margin is 24.00% and weekly performance is -15.67%. On last trading day company shares ended up $38.86. Analysts mean target price for the company is $48.75. Dr. Reddy’s Laboratories Limited (ADR) (NYSE:RDY) distance from 50-day simple moving average (SMA50) is -11.77%.
Switzerland-based drug giant Novartis AG (ADR) (NYSE:NVS) suffered a rejection in the hands of the U.S. Food and Drug Administration (FDA) that declined to approved its much-touted heart failure medication, serelaxin or RLX030. Novartis AG (ADR) (NYSE:NVS) shares fell -0.40% in last trading session and ended the day on $89.52. NVS gross Margin is 66.50% and its return on assets is 7.80%.Novartis AG (ADR) (NYSE:NVS) quarterly performance is 11.87%.
Police handed a case to prosecutors alleging that the former head of GlaxoSmithKline Plc (NYSE:GSK)’s China unit, British national Mark Reilly, ordered sales teams to bribe hospitals and doctors. Glaxo has said it’s cooperating with the authorities. GlaxoSmithKline plc (ADR) (NYSE:GSK) shares moved down -1.06% in last trading session and was closed at $54.84, while trading in range of $54.66 – $55.02. GlaxoSmithKline plc (ADR) (NYSE:GSK) year to date (YTD) performance is 5.30%.
Abbott Laboratories (NYSE:ABT) rose 1.5 percent after financial analysts cheered the medical device maker’s proposed acquisition of CFR Pharmaceuticals for nearly $3 billion. Abbott Laboratories (NYSE:ABT) ended the last trading day at $39.63. Company weekly volatility is calculated as 1.63% and price to cash ratio as 8.45.Abbott Laboratories (NYSE:ABT) showed a positive weekly performance of 0.92%.
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) lost a bid to block approval of a generic form of Copaxone, a multiple sclerosis drug that may account for half the company’s profit, 10 days before the patent on the medication expires. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) net profit margin is 6.80% and weekly performance is 0.62%. On last trading day company shares ended up $49.95. Analysts mean target price for the company is $55.91. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) distance from 50-day simple moving average (SMA50) is 0.06%.